(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
The most effective method to Refresh the Infotainment Framework in the Volvo XC40 - 2Help Your Efficiency with These Work area Updates
- 3James Webb Space Telescope discovers a lemon-shaped exoplanet unlike anything seen before: 'What the heck is this?'
- 4Video Conferencing Instruments for Virtual Gatherings
- 5Catch the moon dancing with bright star Regulus tonight
- Step by step instructions to Think about Disc Rates Across Various Banks
- Why the chemtrail conspiracy theory lingers and grows – and why Tucker Carlson is talking about it
- The race is on to turn your body into a GLP-1 factory
- How to watch ‘The Traitors’ Season 4: Premiere date, episode release time, full cast list and more
- Vote In favor of Your Favored Shades
- The Secret Side of Italy: 12 Underrated Destinations Locals Don’t Want Tourists to Find
- Study reveals links between global food systems, obesity, and climate change
- Parents who delay baby's first vaccines also likely to skip measles shots
- Why is Jerome Powell being investigated? Making sense of the DOJ's probe into the Federal Reserve chair.
